Is there a Role for Conservative Treatment in Those With Unilateral Tubal Occlusion?

Main Article Content

Anthony Eschliman Stephanie Welsh Alan M. Martinez Rose Maxwell Julie M. Sroga Steven Robert Lindheim

Abstract

HSG is the accepted standard to diagnose tubal patency. In contrast to bilateral tubal occlusion where therapy is directed towards laparoscopic correction or IVF, treatment of unilateral tubal occlusion (UTO) is less clear, including conservative OI and IUI directed towards the patent tube. We assessed the value of conservative OI-IUI and pregnancy outcomes in those with UTO. Methods: We evaluated patients diagnosed on HSG with UTO (n=24) (proximal [n=7] and mid-distal or distal occlusion [n=17]). Inclusion included women <38 years; regular menstrual cycles; normal sperm parameters; and normal spill from 1 fallopian tube on HSG.  Controls underwent donor insemination (n=87 in 275 cycles) with bilateral tubal spill. Treatment included LH testing and time intercourse (n=5) or OI-IUI with Clomiphene Citrate or Letrazole (n=19 in 36 cycles). All treatment cycles were monitored by ultrasound; hCG was given when lead follicle size reached >18mm (unless recruited follicle on obstructed side); and IUI was performed 24-36 hours later. The primary outcome measured was clinical pregnancy (CP). Results: Baseline demographics including age (32.2±4[±SD] vs 33.4±2 yrs, p-NS) and BMI (27.9±7 vs 28.2±8 kg/m2, p-NS) were similar between UTO and control groups. Between HSG and treatment, spontaneous pregnancy occurred in 5 (21%) women with UTO (1 proximal, 4 distal). In those undergoing OI-IUI treatment, CP rates/patient (32%, n=6/19 and 24%, n=21/87, p=0.56) and CP/cycle (17%, 6/36 and 8%, 21/275, p=0.10) were similar for UTO and control groups.  Overall, CP occurred in 2 (29%) and 9 (53%) patients with proximal and mid-distal or distal UTO, p=0.005, respectively. Twenty-nine (81%) cycles recruited a dominant follicle on the patent side (19% CP/cycle), in contrast no pregnancies occurred (0%, 0/7) if recruitment occurred on the side of UTO, p=0.3. Conclusions: Pregnancy rates are not compromised in women with UTO and conservative treatment with OI-IUI appears justified as a first line approach, obviating more aggressive therapies including laparoscopy and IVF.

Article Details

How to Cite
ESCHLIMAN, Anthony et al. Is there a Role for Conservative Treatment in Those With Unilateral Tubal Occlusion?. Medical Research Archives, [S.l.], n. 2, apr. 2015. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/39>. Date accessed: 29 mar. 2024.
Keywords
infertility, unilateral tubal occlusion, ovulation induction, laparoscopy
Section
Review Articles

References

1. Saunders RD, Shwayder JM, Nakajima ST. Current methods of tubal patency assessment. Fertil Steril 2011; 95(7):2171-9.

2. Tanahatoe S, Lambalk C, McDonnell J, Dekker J, Mijatovic V, Hompes P. Diagnostic laparoscopy is needed after abnormal hysterosalpingography to prevent over-treatment with IVF. Reprod Biomed Online. 2008 Mar;16(3):410-5.

3. Lavy Y, Lev-Sagle A, Holtzer H, Revel A, Hurwitz A. Should Laparoscopy be a mandatory component of the infertility evaluation In infertile women with normal hysterosalpingogram or suspected unilateral distal tubal pathology? Eur J Obstet Gynecol Reprod Biol 2004;114(1):64-8.

4. Farhi J, Ben-Haroush A, Lande Y, Fisch B. Role of treatment with ovarian stimulation and intrauterine insemination in women with unilateral tubal occlusion diagnosed by hysterosalpingography. Fertil Steril 2007: 88(2):396-400.

5. Lin, Ming-Huei et al. Treatment of infertile women with unilateral tubal occlusion by intrauterine insemination and ovarian stimulation. Taiwan J Obstet Gynecol 2013: 52(3):360-364.

6. Yi G, Jee B, Suh C, Kim S. Stimulated intrauterine insemination in women with unilateral tubal occlusion. Clin Exp Reprod Med 2012: 39(2):68-72.

7. Berker B, Ye S, Kahraman K, Atabekoglu CS, Sonmezer M, Ozmen B, Ates C. Impact of unilateral tubal blockage diagnosed by hysteroslapingography on the success rate of treatment with controlled ovarian stimulation and intrauterine insemination. J Obsete Gynaecol 2014: 34(2): 127-30.

8. Saitou Y, Sugimoto K, Saitou M, Hayashi H, Yanaihara N, Tanaka T. Efficacy of Ovarian Stimulation and Intrauterine Insemination in Women with Unilateral Tubal Occlusion Diagnosed by Hysterosalpingography. Jikaikai Med J 2010: 59; 1-4.

9. Ebrahimi M, Asbagh F, Ghaseminejad A. Controlled ovarian hyperstimulation and intrauterine insemination cycles in patients with unilateral tubal blockage diagnosed by hysterosalpingography. Iran J Reprod Med 2011: 9(1):15-20.

10. “Side Effects of Injectable Fertility Drugs (gonadotropins)." ASRM.org. American Society for Reproductive Medicine, 2012. Web.

11. Strandell A, Lindhard A. Why does hydrosalpinx reduce fertility? Hum Reprod 2002: 17(5): 1141-45.

12. Mol B, Collins J, Burrows E, van der Veen F, Bossuyt, P. Comparison of hysterosalpingography and laparoscopy in predicting fertility outcome. Hum Reprod 1999: 14 (5): 1237-1242.